Evaluation of Investigational (Frequent Replacement) FRP Lens for Daily Wear

Sponsor
Coopervision, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT02362724
Collaborator
(none)
89
6
2
10
14.8
1.5

Study Details

Study Description

Brief Summary

The purpose of the study is to compare the investigational contact lens to a marketed contact lens.

The study results were not used for design validation of investigational contact lens,

Condition or Disease Intervention/Treatment Phase
  • Device: Sapphire
  • Device: Pearl
N/A

Detailed Description

The objective of this evaluation is to provide evidence supporting the claim that the performance of the Test Lens is substantially equivalent to that of the Control Lens when used in a one month (up to 30 days) recommended replacement, daily wear modality.

The study results were not used for design validation of investigational contact lens,

Study Design

Study Type:
Interventional
Actual Enrollment :
89 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Evaluation of the CooperVision, Inc. Sapphire and Pearl Silicone Hydrogel Daily Wear Contact Lenses When Used for Frequent Replacement for Up to One (1) Month of Daily Wear.
Study Start Date :
Feb 1, 2015
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sapphire

Subjects randomized to the experimental contact lens over the study duration

Device: Sapphire
silicone hydrogel contact lens

Active Comparator: Pearl

Subjects randomized to the active comparator contact lens over the study duration

Device: Pearl
silicone hydrogel contact lens

Outcome Measures

Primary Outcome Measures

  1. Slit Lamp Findings for Epithelial Edema [Baseline (After lens dispensing)]

    Slit Lamp Findings for Epithelial Edema on a grade of 0-4 (0 NONE: No microcysts; normal transparency, 1 TRACE: 1 to 20 microcysts; barely discernible local epithelial haziness, 2 MILD: 21 to 50 microcysts; faint but definite localized or generalized haziness, 3 MODERATE: 51 to 100 microcysts; significant localized or generalized haziness, 4 SEVERE: >100 microcysts; definite widespread epithelial cloudiness giving a dull glass appearance to the cornea, or numerous coalescing bullae)

  2. Slit Lamp Findings for Epithelial Edema [1 Month]

    Slit Lamp Findings for Epithelial Edema on a grade of 0-4 (0 NONE: No microcysts; normal transparency, 1 TRACE: 1 to 20 microcysts; barely discernible local epithelial haziness, 2 MILD: 21 to 50 microcysts; faint but definite localized or generalized haziness, 3 MODERATE: 51 to 100 microcysts; significant localized or generalized haziness, 4 SEVERE: >100 microcysts; definite widespread epithelial cloudiness giving a dull glass appearance to the cornea, or numerous coalescing bullae)

  3. Slit Lamp Findings for Stromal Edema [Baseline (After lens dispensing)]

    Slit Lamp Findings for Stromal Edema on a grade of 0-4 (0 NONE: No edema, 1 TRACE: Just detectable clouding, 2 MILD: Faint corneal striae (2 or fewer), 3 MODERATE: Pronounced corneal striae (3), 4 SEVERE: Folds in Descemet's membrane and >4 pronounced striae)

  4. Slit Lamp Findings for Stromal Edema [1 month]

    Slit Lamp Findings for Stromal Edema on a grade of 0-4 (0 NONE: No edema, 1 TRACE: Just detectable clouding, 2 MILD: Faint corneal striae (2 or fewer), 3 MODERATE: Pronounced corneal striae (3), 4 SEVERE: Folds in Descemet's membrane and >4 pronounced striae)

  5. Slit Lamp Findings for Corneal Infiltrates [Baseline (After lens dispensing)]

    Slit Lamp Findings for Corneal Infiltrates - Present, Absent

  6. Slit Lamp Findings for Corneal Infiltrates [1 Month]

    Slit Lamp Findings for Corneal Infiltrates - Present, Absent

  7. Slit Lamp Findings for Corneal Vascularization [Baseline (After lens dispensing)]

    Slit Lamp Findings for Corneal Vascularization on a grade 0-4 (0 NONE: No vessel penetration, 1 TRACE: <1.00 mm vessel penetration, 2 MILD: >1.00 mm to <1.50 mm vessel penetration, 3 MODERATE: >1.50 mm to <2.00 mm vessel penetration, 4 SEVERE: Vessel penetration >2.00 mm)

  8. Slit Lamp Findings for Corneal Vascularization [1 month]

    Slit Lamp Findings for Corneal Vascularization on a grade 0-4 (0 NONE: No vessel penetration, 1 TRACE: <1.00 mm vessel penetration, 2 MILD: >1.00 mm to <1.50 mm vessel penetration, 3 MODERATE: >1.50 mm to <2.00 mm vessel penetration, 4 SEVERE: Vessel penetration >2.00 mm)

  9. Slit Lamp Findings for Limbal Hyperemia [Baseline (After lens dispensing)]

    Slit Lamp Findings for Limbal Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)

  10. Slit Lamp Findings for Limbal Hyperemia [1 month]

    Slit Lamp Findings for Limbal Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)

  11. Slit Lamp Findings for Bulbar Hyperemia [Baseline (After lens dispensing)]

    Slit Lamp Findings for Bulbar Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)

  12. Slit Lamp Findings for Bulbar Hyperemia [1 month]

    Slit Lamp Findings for Bulbar Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)

  13. Slit Lamp Findings for Palpebral Conjunctiva [Baseline (After lens dispensing)]

    Slit Lamp Findings for Palpebral Conjunctiva - Present, Absent

  14. Slit Lamp Findings for Palpebral Conjunctiva [1 month]

    Slit Lamp Findings for Palpebral Conjunctiva - Present, Absent

  15. Slit Lamp Findings for Other Findings [Baseline (After lens dispensing)]

    Slit Lamp Findings for Other findings (conjunctival infection, corneal ulcers, iritis, lens adhesions and recurrent erosion) on a grade 0-4 (0 NONE, 1 TRACE, 2 MILD, 3 MODERATE, 4 SEVERE)

  16. Slit Lamp Findings for Other Findings [1 month]

    Slit Lamp Findings for Other findings (conjunctival infection, corneal ulcers, iritis, lens adhesions and recurrent erosion) on a grade 0-4 (0 NONE, 1 TRACE, 2 MILD, 3 MODERATE, 4 SEVERE)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Prior to being considered eligible to participate in this study, each subject MUST:
  1. Be at least 18 years of age as of the date of evaluation for the study.

  2. Have:

  3. Read the Informed Consent

  4. been given an explanation of the Informed Consent

  5. indicated understanding of the Informed Consent

  6. signed the Informed Consent document.

  7. Be willing and able to adhere to the instructions set forth in this protocol and able to keep all specified appointments.

  8. Be an adapted, current full-time silicone hydrogel or soft contact lens wearer. An adapted full-time wearer is defined as wearing contact lenses at least 5 days per week for at least 8 hours per day for at least one month prior to participation in the study.

  9. Possess or obtain prior to dispensing, wearable and visually functional (20/40 or better) eyeglasses.

  10. Be in good general health, based on his/her knowledge.

  11. Require spectacle lens powers between -0.50 and -8.00 diopters sphere with no more than 1.50 diopter of refractive astigmatism and be willing to wear contact lenses in both eyes.

  12. Have manifest refraction Snellen visual acuities (VA) equal to or better than 20/25 in each eye.

  13. To be eligible for lens dispensing, the subject must achieve 20/30 VA or better in each eye with the study lens and the investigator must judge the fit as acceptable or optimal.

Exclusion Criteria:
  • Subjects may not be enrolled in this study if any of the following apply: The subject is currently or has:
  1. Wearing lenses in a monovision modality and is unwilling to be fit with distance lenses in both eyes for the duration of the study. NOTE: Subjects may not wear lenses in a monovision modality at any time during the study as it will interfere with the visual acuity analysis.

  2. Poor personal hygiene.

  3. Any active participation in another clinical trial during this trial or within 30 days prior to this study.

  4. To the best of the subject's knowledge, she is currently pregnant, is lactating or is planning a pregnancy within the next 3 months.

  5. A member, relative or household member of the investigator or of the investigational office staff.

  6. Has a known sensitivity to the ingredients used in the MPS approved for use in the study and is unable or unwilling to use the alternate care system.

  7. Previous refractive surgery; or current or previous orthokeratology treatment.

  8. Is aphakic or psuedophakic.

  9. Ocular or systemic disease such as, but not limited to: anterior uveitis or iritis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, scleroderma, keratoconus or uncontrolled diabetes.

  10. The need for topical ocular medications or any systemic medication which might interfere with contact lens wear or require the lenses to be removed during the day.

  11. The presence of clinically significant (grade 2, 3 or 4) anterior segment abnormalities; or the presence of any inflammations such as iritis; or any infection of the eye, lids, or associated structures.

  12. A known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates, iritis, bacterial or fungal infections.

  13. A history of papillary conjunctivitis that has interfered with contact lens wear.

  14. Slit lamp findings that would contraindicate contact lens wear, including but not limited to:

  • Pathological dry eye or associated dry eye symptoms with decreased tear levels and punctuate staining > Grade 2

  • Pterygium

  • Corneal scars within the visual axis

  • Neovascularization or ghost vessels > 1.0 mm in from the limbus

  • Giant papillary conjunctivitis (GPC) of > Grade 2

  • Anterior uveitis or iritis

  • Seborrheic eczema, seborrheic conjunctivitis or blepharitis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Eric M White OD, Inc. San Diego California United States 92123
2 Office of Mark E Nakano, O.D. Torrance California United States 90503
3 Advanced Family Eye Care Denver North Carolina United States 28037
4 Quinn Foster & Associates Athens Ohio United States 45701
5 Primary Eyecare Group, P.C. Brentwood Tennessee United States 37027
6 Premier Vision Services, LLC Amarillo Texas United States 79119

Sponsors and Collaborators

  • Coopervision, Inc.

Investigators

  • Study Chair: Steven L Saltzman, MD, FACOG, Sterling IRB

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Coopervision, Inc.
ClinicalTrials.gov Identifier:
NCT02362724
Other Study ID Numbers:
  • FC131202
First Posted:
Feb 13, 2015
Last Update Posted:
Oct 14, 2020
Last Verified:
Dec 1, 2015
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Period Title: Overall Study
STARTED 59 30
COMPLETED 53 29
NOT COMPLETED 6 1

Baseline Characteristics

Arm/Group Title Sapphire Pearl Total
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens Total of all reporting groups
Overall Participants 59 30 89
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
Between 18 and 65 years
59
100%
30
100%
89
100%
>=65 years
0
0%
0
0%
0
0%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
32.8
(8.820)
33.3
(8.890)
32.9
(8.800)
Sex: Female, Male (Count of Participants)
Female
40
67.8%
18
60%
58
65.2%
Male
19
32.2%
12
40%
31
34.8%
Race/Ethnicity, Customized (participants) [Number]
Asian
1
1.7%
0
0%
1
1.1%
White
47
79.7%
23
76.7%
70
78.7%
Japanese
9
15.3%
5
16.7%
14
15.7%
Black
1
1.7%
1
3.3%
2
2.2%
Hispanic
1
1.7%
1
3.3%
2
2.2%
Other
1
1.7%
0
0%
1
1.1%
Region of Enrollment (participants) [Number]
United States
59
100%
30
100%
89
100%

Outcome Measures

1. Primary Outcome
Title Slit Lamp Findings for Epithelial Edema
Description Slit Lamp Findings for Epithelial Edema on a grade of 0-4 (0 NONE: No microcysts; normal transparency, 1 TRACE: 1 to 20 microcysts; barely discernible local epithelial haziness, 2 MILD: 21 to 50 microcysts; faint but definite localized or generalized haziness, 3 MODERATE: 51 to 100 microcysts; significant localized or generalized haziness, 4 SEVERE: >100 microcysts; definite widespread epithelial cloudiness giving a dull glass appearance to the cornea, or numerous coalescing bullae)
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 58
Grade 0
106
58
Grade 1
0
0
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
2. Primary Outcome
Title Slit Lamp Findings for Epithelial Edema
Description Slit Lamp Findings for Epithelial Edema on a grade of 0-4 (0 NONE: No microcysts; normal transparency, 1 TRACE: 1 to 20 microcysts; barely discernible local epithelial haziness, 2 MILD: 21 to 50 microcysts; faint but definite localized or generalized haziness, 3 MODERATE: 51 to 100 microcysts; significant localized or generalized haziness, 4 SEVERE: >100 microcysts; definite widespread epithelial cloudiness giving a dull glass appearance to the cornea, or numerous coalescing bullae)
Time Frame 1 Month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected.
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Grade 0
104
56
Grade 1
0
0
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
3. Primary Outcome
Title Slit Lamp Findings for Stromal Edema
Description Slit Lamp Findings for Stromal Edema on a grade of 0-4 (0 NONE: No edema, 1 TRACE: Just detectable clouding, 2 MILD: Faint corneal striae (2 or fewer), 3 MODERATE: Pronounced corneal striae (3), 4 SEVERE: Folds in Descemet's membrane and >4 pronounced striae)
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 58
Grade 0
106
58
Grade 1
0
0
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
4. Primary Outcome
Title Slit Lamp Findings for Stromal Edema
Description Slit Lamp Findings for Stromal Edema on a grade of 0-4 (0 NONE: No edema, 1 TRACE: Just detectable clouding, 2 MILD: Faint corneal striae (2 or fewer), 3 MODERATE: Pronounced corneal striae (3), 4 SEVERE: Folds in Descemet's membrane and >4 pronounced striae)
Time Frame 1 month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Grade 0
104
56
Grade 1
0
0
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
5. Primary Outcome
Title Slit Lamp Findings for Corneal Infiltrates
Description Slit Lamp Findings for Corneal Infiltrates - Present, Absent
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 58
Present
0
0
Absent
106
58
6. Primary Outcome
Title Slit Lamp Findings for Corneal Infiltrates
Description Slit Lamp Findings for Corneal Infiltrates - Present, Absent
Time Frame 1 Month

Outcome Measure Data

Analysis Population Description
Data for two test lens and two control lens were not collected
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Present
0
0
Absent
104
56
7. Primary Outcome
Title Slit Lamp Findings for Corneal Vascularization
Description Slit Lamp Findings for Corneal Vascularization on a grade 0-4 (0 NONE: No vessel penetration, 1 TRACE: <1.00 mm vessel penetration, 2 MILD: >1.00 mm to <1.50 mm vessel penetration, 3 MODERATE: >1.50 mm to <2.00 mm vessel penetration, 4 SEVERE: Vessel penetration >2.00 mm)
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 58
Grade 0
103
52
Grade 1
3
6
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
8. Primary Outcome
Title Slit Lamp Findings for Corneal Vascularization
Description Slit Lamp Findings for Corneal Vascularization on a grade 0-4 (0 NONE: No vessel penetration, 1 TRACE: <1.00 mm vessel penetration, 2 MILD: >1.00 mm to <1.50 mm vessel penetration, 3 MODERATE: >1.50 mm to <2.00 mm vessel penetration, 4 SEVERE: Vessel penetration >2.00 mm)
Time Frame 1 month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Grade 0
101
52
Grade 1
3
4
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
9. Primary Outcome
Title Slit Lamp Findings for Limbal Hyperemia
Description Slit Lamp Findings for Limbal Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 58
Grade 0
77
48
Grade 1
29
10
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
10. Primary Outcome
Title Slit Lamp Findings for Limbal Hyperemia
Description Slit Lamp Findings for Limbal Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)
Time Frame 1 month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected.
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Grade 0
76
44
Grade 1
28
12
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
11. Primary Outcome
Title Slit Lamp Findings for Bulbar Hyperemia
Description Slit Lamp Findings for Bulbar Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 56
Grade 0
64
41
Grade 1
42
17
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
12. Primary Outcome
Title Slit Lamp Findings for Bulbar Hyperemia
Description Slit Lamp Findings for Bulbar Hyperemia on a grade 0-4 (0 NONE: No hyperemia present, 1 TRACE: Slight regional hyperemia, 2 MILD: Diffuse hyperemia, 3 MODERATE: Marked regional or diffuse hyperemia, 4 SEVERE: Diffuse episcleral or scleral hyperemia)
Time Frame 1 month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected.
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Grade 0
70
42
Grade 1
33
14
Grade 2
1
0
Grade 3
0
0
Grade 4
0
0
13. Primary Outcome
Title Slit Lamp Findings for Palpebral Conjunctiva
Description Slit Lamp Findings for Palpebral Conjunctiva - Present, Absent
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 58
Present
34
19
Absent
72
39
14. Primary Outcome
Title Slit Lamp Findings for Palpebral Conjunctiva
Description Slit Lamp Findings for Palpebral Conjunctiva - Present, Absent
Time Frame 1 month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Present
47
20
Absent
57
36
15. Primary Outcome
Title Slit Lamp Findings for Other Findings
Description Slit Lamp Findings for Other findings (conjunctival infection, corneal ulcers, iritis, lens adhesions and recurrent erosion) on a grade 0-4 (0 NONE, 1 TRACE, 2 MILD, 3 MODERATE, 4 SEVERE)
Time Frame Baseline (After lens dispensing)

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 53 29
Measure Eyes 106 56
Grade 0
104
54
Grade 1
2
4
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0
16. Primary Outcome
Title Slit Lamp Findings for Other Findings
Description Slit Lamp Findings for Other findings (conjunctival infection, corneal ulcers, iritis, lens adhesions and recurrent erosion) on a grade 0-4 (0 NONE, 1 TRACE, 2 MILD, 3 MODERATE, 4 SEVERE)
Time Frame 1 month

Outcome Measure Data

Analysis Population Description
Data for two test eyes and two control eyes were not collected
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
Measure Participants 52 28
Measure Eyes 104 56
Grade 0
101
54
Grade 1
3
2
Grade 2
0
0
Grade 3
0
0
Grade 4
0
0

Adverse Events

Time Frame From Dispense up to one month on study lenses
Adverse Event Reporting Description
Arm/Group Title Sapphire Pearl
Arm/Group Description Subjects were randomized in a 2:1(Test: Control) ratio to the experimental contact lens over the study duration Sapphire: silicone hydrogel contact lens Subjects were randomized in a 2: 1 ratio (Test: Control) to the active comparator contact lens over the study duration Pearl: silicone hydrogel contact lens
All Cause Mortality
Sapphire Pearl
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/59 (0%) 0/30 (0%)
Serious Adverse Events
Sapphire Pearl
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/59 (0%) 0/30 (0%)
Other (Not Including Serious) Adverse Events
Sapphire Pearl
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 7/59 (11.9%) 2/30 (6.7%)
Eye disorders
Pappilary Conjuctivitis 6/59 (10.2%) 6 1/30 (3.3%) 1
Corneal Infiltrate 0/59 (0%) 0 1/30 (3.3%) 1
Foreign body Abrasion 1/59 (1.7%) 1 0/30 (0%) 0

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Myhanh Nguyen
Organization CooperVision, Inc.
Phone 925-730-6716
Email mnguyen@coopervision.com
Responsible Party:
Coopervision, Inc.
ClinicalTrials.gov Identifier:
NCT02362724
Other Study ID Numbers:
  • FC131202
First Posted:
Feb 13, 2015
Last Update Posted:
Oct 14, 2020
Last Verified:
Dec 1, 2015